The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have...
Transcript of The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have...
![Page 1: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/1.jpg)
The future of probiotics:as illustrated by the Protexin company
Peter CartwrightMSc, MA, BSc, BA(Hons)
![Page 2: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/2.jpg)
Structure of lecture
1. Introduction2. Protexin’s history and approach3. Advances in science, and changes in
regulation4. Condition-specific products, and research
programmes
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 2
![Page 3: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/3.jpg)
1. Introduction: Peter Cartwright
•Microbiologist–MSc Microbiology, BSc Biomedicine
• Human microbiota specialist with Protexin
• Manages human product research programmes
• 17 years’ experience leading patient associations
• Lecturer on probiotics - >50 talks to doctors in 14 countries
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 3
![Page 4: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/4.jpg)
Author of books on intestinal health
• Independent author of 4 books:–on probiotics, ulcerative
colitis and diverticulitis
• Including Probiotics for Crohn’s & Colitis
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 4
![Page 5: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/5.jpg)
Definition of probiotics
“live microorganisms which when administered in adequate amounts confer a health benefit on the host”
(Joint FAO/WHO, 2002)
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 5
![Page 6: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/6.jpg)
2. Protexin’s history and approach
•Exclusively a probiotics company
•Formed in 1992, in Somerset, England
•Farmers recognised anti-pathogen properties of lactic acid bacteria
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 6
![Page 7: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/7.jpg)
Probiotics support the gut microbiota
Duodenum10,000/ml
Ileum100,000,000/ml
Stomach1,000/ml
Jejunum100,000/ml
Large intestineUp to 1,000,000,000,000/gm
![Page 8: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/8.jpg)
Human probiotic products developed
•Public readily accept probiotic concept
•Familiarity with yoghurt•Gut protection and accelerated recovery
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 8
![Page 9: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/9.jpg)
Principles of products:
• Selecting strains on basis of range of properties• Only ‘natural’ strains used
–species normally found in human gut–no genetic engineering
• Safety of strains checked:–Antibiotic resistance–Toxin production
• High quality production• Associated educational services
–Literature, website and lectures
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 9
![Page 10: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/10.jpg)
Lactobacillus spp.
Bifidobacterium spp.
Microbes commonly used as probiotics
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 10
![Page 11: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/11.jpg)
Understanding strains further
• Reading University, Berkshire, England
• Research led by Profs. Glenn Gibson & Ian Rowland
• Examining Protexin strains for:–antimicrobial activity–mechanisms of action– inter-strain synergies
• Publications (Chapman et al, 2011; Chapman et al, 2012; Tejero-Sarinena et al, 2012)
• Sample slide of researcher followsProf. Glenn Gibson
Prof. Ian Rowland
![Page 12: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/12.jpg)
Batch Culture fermentationsby Sandra Tejero
In vitro, anaerobic, stirred, pH (6.7-6.9) and temperature (37°C) controlled batch cultures
3 faecal donors
1% (v/v) faecal slurry
Gut model media
againstS. Typhimurium
C. difficile
L. casei PXN 37L. acidophilus PXN 35B. breve PXN 25Mix of 15
The following combinations will be tested in every batch culture run:
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 12
![Page 13: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/13.jpg)
High quality production• Pharmaceutical grade
production• Good manufacturing practice
(GMP) – awarded by the UK Govt’s Medicines and Healthcare Products Regulatory Agency
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 13
![Page 14: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/14.jpg)
Protexin is member of:
• International Scientific Association for Probiotics and Prebiotics (ISAPP)
• International Probiotic Association (IPA)
• Health Food Manufacturers Association (HFMA)
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 14
![Page 15: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/15.jpg)
Different probiotic genera/species/strains have different properties• Multi-strain offers wider protection, and potential for synergy
(Chapman et al, 2012; Timmerman et al, 2004)
• Also, some species found in certain age groupsBifidobacterium infantis more common in babies, due to ability to digest human milk oligosaccharides(Sela et al, 2008)
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 15
![Page 16: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/16.jpg)
Evidence of benefit from Protexin products
Day Control(n=27)
Control(n=27)
ProtexinRestore
(n=24)
ProtexinRestore
(n=24)
Significance(p<0.05)
Frequency Mean Frequency Mean
1 131 4.85 118 4.91 0.928
2 125 4.63 63 2.65 0.017
3 74 2.74 18 0.75 0.000
4 40 1.48 6 0.25 0.055
Acute gastroenteritis in infantsFrequency of purging
Yala (2010) PIDSP Journal 11: 86-91.
• Initial dose within six hours of hospital admission• Significant reduction in duration of hospital stay
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 16
![Page 17: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/17.jpg)
Helicobacter pylori infection in children(treatment in addition to ‘triple therapy’ of antibiotics and PPI)
H. pylori Protexin Restore
Placebo P. value
Eradicated 30 (90.9%) 23 (69.7%) 0.04
Not eradicated 3 (9.1%) 10 (30.3%)
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 17
Protexin Restore reduced side effects of drugs:Nausea/vomiting (p = 0.02)Diarrhoea (p = 0.04)
Khodadad et al (2013) Iranian Journal of Pediatrics 23: 79-84
![Page 18: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/18.jpg)
Benefit from Protexin Balancein constipated adults
Balance(n=31)
Placebo(n=29)
Mean difference
Baseline 2.29 2.17 0.11
Week 2 4.81 3.48 1.32
Week 4 5.45 3.86 1.58
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 18
Increased stool frequency (SF) in Protexin Balance group (SF/week) [p=0.02]53% increase after 2 weeks;64% increase after 4 weeks (ex-placebo effect)Study group: constipated males
Fateh et al (2011) Swiss Medical Weekly 141: w13239
![Page 19: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/19.jpg)
3. Changes in science and regulation
• Recent scientific developments:• Improved understanding of the fundamentals• Understanding healthy gut microflora
–Metagenomics (mapping species)–How species inter-relate (eg: by-product of one species used by
another)–Dysbioses in different GI conditions
• Bacterial influences on immune system• Role of bacteria in brain-gut axis (eg: IBS)• Effects on metabolism (eg: obesity)
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 19
![Page 20: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/20.jpg)
A change in regulation
• European Commission regulation EC1924/2006
• Health claims on foods• To protect public from false
claims• List of approved claims
came into force July 2012
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 20
![Page 21: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/21.jpg)
No probiotic products on first official list
•Classified as food supplement–Idea developed from
yoghurts
•All clinical trials in diseased populations rejected by EFSA
•Food not allowed to make claim about disease
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 21
![Page 22: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/22.jpg)
Probiotics as medicines
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 22
• Companies and scientists increasingly focus on probiotics as medicine
• Discovering what EMA requires of live biotherapeutic microbes
• Enquiries led by Pharmabiotic Research Institute
![Page 23: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/23.jpg)
4. Condition-specific research• Increased knowledge of gut
microbiota, plus greater interest in probiotics as licensed medicines
• Plans for condition-specific products by Protexin
• Research team based at the Blizard Institute (School of Medicine, Queen Mary College, University of London)
• This research programme started in May 2011
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 23
![Page 24: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/24.jpg)
Main personnel(from Blizard Institute)
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 24
Prof. Lucinda Hall Microbiologist
Prof. Qasim AzizConsultant Gastroenterologist
Prof. Gareth Sanger Neurophysiologist
![Page 25: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/25.jpg)
Research in four parts• Screening strains for general desirable qualities• Screening strains for condition-specific properties• Human study in healthy volunteers• Two human studies in target patients:
–Pilot trial–Full randomised controlled trial
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 25
![Page 26: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/26.jpg)
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 26
257 strains for screening process:selection by in vitro assays of mucosal adhesion and acid/bile survival
3 CultureCollections(37 strains)
Protexincurrent
strains (12)
Biopsyisolates
(48 strains)
Czech Uni.(142 strainsscreened)
Shortlist of 10 strains
4 strains forhuman studies
Scottishculture collection
(47 strainsscreened)
![Page 27: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/27.jpg)
Biopsy isolates
•Future strains sourced from healthy human gut mucosal surface
•Routine screening process (colonoscopy)
• Isolation of lactobacilli and bifidobacteria for screening tests
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 27
![Page 28: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/28.jpg)
In vitro tests to identify best bacterial strains
•Tests for:–Stomach and duodenum
survival (acid and bile)–Mucosal adhesion (auto-
aggregation, mucin adhesion)
•Anti-pathogen effects relevant to condition
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 28
![Page 29: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/29.jpg)
Secondary benefit of research:Protexin ‘Pool’ of superior strains for future research
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 29
• Twenty strains superior to ‘gold standard’ strains
• Stored at -80°C in specialist culture collections
![Page 30: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/30.jpg)
Other condition-specific research:prevention and treatment of diarrhoea caused by Clostridium difficile infection• Broad-spectrum antibiotics
disturb gut microflora• Clostridium difficile takes
advantage of damaged microflora to cause diarrhoea
• Eradication of C. difficile is becoming more difficult
– increase of antibiotic-resistant strains
–especially in hospitals
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 30
![Page 31: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/31.jpg)
Protexin strain has early evidence of effect against C. difficile• Bacillus subtilis PXN21• Species used widely to treat
diarrhoea• Soil bacterium• Life-cycle includes transit through
mammalian gut (including human)• Forms spores, which protect against
stomach acid
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 31
![Page 32: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/32.jpg)
Properties of Protexin strain examined at Royal Hollway College, Univ. of London•Work overseen by Prof. Simon Cutting
•A world leader in bacilli as probiotics
•Examining:–Ability to bind toxins– Immune regulation–Effect against Clostridium
difficile
![Page 33: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/33.jpg)
Further information on probiotics
•Probiotic Allies by Peter Cartwright
•Describes the various microbiota
•Evidence of benefit from probiotics in various gut conditions
•Available from VitaminKosar Kft.
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 33
![Page 34: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/34.jpg)
Summary
• Protexin is well established specialist company:–Activities illustrate current and future state of probiotics
• Multi-strain products to GMP standards• Changes in regulation and in scientific knowledge• Moves towards probiotics as medicines• Condition-specific probiotics in the future
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 34
![Page 35: The future of probiotics - drprobiotikum.hu · Different probiotic genera/species/strains have different properties •Multi-strain offers wider protection, and potential for synergy](https://reader034.fdocuments.us/reader034/viewer/2022050111/5f48f1afc67773433c295138/html5/thumbnails/35.jpg)
References• Chapman, C.M., Gibson, G.R. & Rowland, I. (2011) Health benefits of probiotics: Are mixtures more effective than single
strains? European Journal of Nutrition 50: 1–17.• Chapman, C.M., Gibson, G.R. & Rowland, I. (2012) In vitro evaluation of single- and multi-strain probiotics: Inter-species
inhibition between probiotic strains, and inhibition of pathogens. Anaerobe 18:405-413. • Fateh, R., Iravani, S., et al. (2011) Synbiotic preparation in men suffering from functional constipation: a randomised
controlled trial. Swiss Medical Weekly 141: w13239.• Joint FAO/WHO Working Group on Evaluation of Probiotics (2002) Guidelines for the Evaluation of Probiotics in Food
(London Ontario, Canada). Food and Agriculture Oganization of the UN/World Health Organization. ftp://ftp.fao.org/es/esn/food/wgreport2.pdf [Accessed 13 September 2010]
• Khodadad, A., Farahmand, F., et al. (2013) Probiotics for the treatment of pediatric Helicobacter pylori infection: a randomised double blind clinical trial. Iranian Journal of Pediatrics 23: 79-84.
• Sela, D.A., Chapman, J., et al. (2008) The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. PNAS 105: 18964-18969.
• Tejero-Sarinena, S., Barlow, J., et al. (2012) In vitro evaluation of the antimicrobial activity of a range of probiotics against pathogens: evidence for the effects of organic acids. Anaerobe 18: 530–538.
• Timmerman, H.M., Konig, C.J., et al. (2004) Monostrain, multistrain and multispecies probiotics – A comparison of functionality and efficacy. International Journal of Food Microbiology 96:219-233
• Yala, E.T. (2010) The clinical efficacy of multi-strain probiotics (Protexin) in the management of acute gastroenteritis in children two months to two years old. PIDSP Journal 11: 86-91.
© Protexin • Futrue of Probiotics • Peter Cartwright 2013 Slide 35